Clinical Pharmacology and Pharmacy of Antimicrobial Agents
In this Special Issue, our aim was to collect studies on clinical pharmacology and pharmacy of antimicrobial agents from both human and veterinary medicine as the complex problem of AMR requires actions taken within the One Health approach that involve both fields. Studies covered here are about new...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_128823 | ||
| 005 | 20231130 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20231130s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-9108-7 | ||
| 020 | |a 9783036591094 | ||
| 020 | |a 9783036591087 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-9108-7 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a MMG |2 bicssc | |
| 100 | 1 | |a Kovács, Dóra |4 edt | |
| 700 | 1 | |a Kovács, Dóra |4 oth | |
| 245 | 1 | 0 | |a Clinical Pharmacology and Pharmacy of Antimicrobial Agents |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (196 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a In this Special Issue, our aim was to collect studies on clinical pharmacology and pharmacy of antimicrobial agents from both human and veterinary medicine as the complex problem of AMR requires actions taken within the One Health approach that involve both fields. Studies covered here are about new or optimized usage of already authorized antimicrobials, as well as discoveries about new agents, new combinations of drugs, and drug repositioning. Pharmacodynamic, pharmacokinetic, and toxicological aspects of individual and combinational drug use are areas covered in this Special Issue. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a antibiotic combination | ||
| 653 | |a minimum inhibitory concentration | ||
| 653 | |a Monte Carlo | ||
| 653 | |a synergistic effect | ||
| 653 | |a antibiotics | ||
| 653 | |a combination therapy | ||
| 653 | |a multi-drug resistant infection | ||
| 653 | |a meta-analysis | ||
| 653 | |a pan-genome | ||
| 653 | |a Campylobacter ureolyticus | ||
| 653 | |a UDP-3-O-acyl-N-acetylglucosamine deacetylase | ||
| 653 | |a LpxC | ||
| 653 | |a campylobacteriosis | ||
| 653 | |a self-medication | ||
| 653 | |a students | ||
| 653 | |a habits | ||
| 653 | |a cystic fibrosis | ||
| 653 | |a P. aeruginosa | ||
| 653 | |a transporters | ||
| 653 | |a Escherichia coli | ||
| 653 | |a suture | ||
| 653 | |a antimicrobial | ||
| 653 | |a pharmacodynamics | ||
| 653 | |a triclosan | ||
| 653 | |a surgical site infection | ||
| 653 | |a time-kill | ||
| 653 | |a contact killing | ||
| 653 | |a translational modelling | ||
| 653 | |a antifungals | ||
| 653 | |a adverse drug reaction (ADR) | ||
| 653 | |a drug-drug interaction (DDI) | ||
| 653 | |a polypharmacy | ||
| 653 | |a multimorbidity | ||
| 653 | |a intensive care patients | ||
| 653 | |a traumatology | ||
| 653 | |a elderly patients | ||
| 653 | |a organ failure | ||
| 653 | |a multi-organ failure | ||
| 653 | |a drug safety | ||
| 653 | |a patient safety | ||
| 653 | |a nonlinear mixed-effects modeling | ||
| 653 | |a glomerular filtration rate | ||
| 653 | |a dosing regimen | ||
| 653 | |a oxacillin | ||
| 653 | |a Monte Carlo simulations | ||
| 653 | |a adsorption | ||
| 653 | |a desorption | ||
| 653 | |a doxycycline | ||
| 653 | |a pH dependence | ||
| 653 | |a small ruminant feed | ||
| 653 | |a heterocyclic compounds | ||
| 653 | |a phenolic compounds | ||
| 653 | |a pyran | ||
| 653 | |a food microbiology | ||
| 653 | |a microbial pathogen | ||
| 653 | |a serum/plasma concentrations | ||
| 653 | |a interstitial concentrations | ||
| 653 | |a tissue concentrations | ||
| 653 | |a pharmacokinetics | ||
| 653 | |a macrolide antibiotics | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/8291 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/128823 |7 0 |z DOAB: description of the publication |